MD
Michael W. Dunne

Michael W. Dunne insider trades: Iterum Therapeutics (ITRM) stock buys and sales

Iterum Therapeutics Last trade Nov 18, 2025 35 Form 4 filings
$0
Sold, last 12 months
0 sales
$2K
Bought, last 12 months
1 buy
10
Open-market trades
since 2018
4
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 18, 2025ITRM↑ Buy$2K
Aug 8, 2025ITRM↑ Buy$11K
Dec 22, 2023ITRM↑ Buy$35K
Dec 18, 2023ITRM↑ Buy$18K
Nov 22, 2023ITRM↑ Buy$41K
Sep 7, 2022ITRM↑ Buy$22K
Jan 26, 2021ITRM↓ Sell$57K
Sep 4, 2018ITRM↑ Buy$5K
Aug 27, 2018ITRM↑ Buy$10K
May 30, 2018ITRM↑ Buy$26K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael W. Dunne's insider trades

Michael W. Dunne is an insider at Iterum Therapeutics (ITRM). Since May 30, 2018, Michael has reported 9 open-market purchases worth $170K and 1 sale worth $57K on SEC Form 4. In the last 12 months: 1 buy ($2K).

Their filings also include grants and awards (16 filings), option exercises (8 filings), other transactions (2 filings), conversions (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ITRM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.